09:14 AM EDT, 03/31/2026 (MT Newswires) -- YD Bio ( YDES ) said Tuesday that it has officially launched the EG Telehealth Platform in collaboration with EG BioMed.

The biotechnology company said the platform is now live and enables access across 44 US states, plus Washington D.C. and Guam.

The platform supports detection and monitoring across multiple cancer types, including pancreatic, colorectal, liver, gastrointestinal, and breast cancers, the company said.